Our physicians are passionate and involved specialists, teaching in regional universities and medical centers, participating in national organizations that monitor and set the standards for reproductive medicine, publishing and presenting frequently, and participating in research to further the knowledge and treatment of infertility.
AMH (Anti-Mullerian Hormone) in Reproductive-Age Women
We are currently conducting a research study to determine the normal range of values of the hormone AMH (anti-mullerian hormone) in reproductive-age women. AMH has been shown to decrease as women age. Better understanding of this hormone may provide information about a woman’s fertility potential.
To better understand the normal range of levels of this hormone in women of reproductive age, we are planning to measure this hormone in women of different ages, with and without a history of infertility. We will compare AMH values to other known markers of fertility potential in an effort to provide women with more information about their chances of conceiving.
Study participants will be compensated $25 for having a single blood draw performed. All identifying information will be removed by the researchers before analyzing the data.
If you are interested in participating in this research study or would like more information, please contact:
Lourella Palao
Clinical Research Coordinator
Click here to contact us about this study
408.356.5000
Previous Research
Auxogyn Eeva™ System Study
FPNC is currently participating in the Auxogyn Eeva System Study. The data collected in this study are intended to demonstrate the effectiveness of the Eeva System to successfully capture and record images of embryo development within a standard incubator and accurately identify those embryos on day 2 that are most likely to form blastocysts. The results may lead to effective methods for embryologists to indentify the most viable embryos so that embryo implantation and pregnancy outcome may be significantly improved for future IVF patients.
FPNC Participating in Nationwide Research Study for In Vitro Fertilization (IVF)
A clinical study comparing the investigational drug corifollitropin alfa to Follistim for ovarian stimulation during in vitro fertilization (IVF).
Fertility Physicians of Northern California was one of multiple clinics nationwide to participate in this research study to compare experimental medication to an approved recombinant-FSH, Follistim®. The study assessed the effectiveness and safety of corifollitropin alfa in female patients undergoing IVF.
Fertility Physicians Research Study for Patients Undergoing IVF Progesterone-IBSA vs. Endometrin®
A nationwide trial comparing experimental progesterone Progesterone IBSA to another progesterone supplement that is placed within the vagina (Endometrin®).
Anastrozole vs. Clomiphene Citrate
The purpose of this multi-center clinical trial was to evaluate the safety and tolerability of anastrozole by comparing it to clomiphene citrate, often known as Clomid® or Serophene®, in women age 18-40 with irregular menstrual cycles undergoing an ovulation induction cycle. The data will be reported to the FDA to seek approval for Anastrozole's use in ovulation induction. At this time Anastrozole is indicated as a treatment for breast cancer and is prescribed "off-label" as a fertility drug.
See letter of inspection here
Gonal-F vs. Fostimon:
This multi-center study evaluated the clinical efficacy and tolerability of two highly purified FSH preparations (Fostimon and Gonal-F) in women undergoing controlled ovarian stimulation for in vitro fertilization. The data will be used to seek approval from the FDA for the use of Fostimon in the United States.
-
Multicenter study to determine the efficacy of Oxiplex™ Barrier Film, which is indicated for use to prevent adhesion formation after laparoscopic gynecological surgery.
FzioMed, San Luis Obispo, CA - Alexis Kim, MD; David Adamson, MD.
-
Multicenter study to determine efficacy and safety of AF0157 for the reduction of post-surgical adhesions after operative laparoscopy.
Alliance Pharmaceutical, San Diego, CA - Alexis Kim, MD; David Adamson, MD.
-
Evidence based guidelines for the use of in vitro fertilization in treating endometriosis.
American Society for Reproductive Medicine - David Adamson, MD.
-
Development of children conceived through IVF/ET and ICSI.
University of Oregon - David Adamson, MD.
See letter of inspection here
|
